Share this Post!

On 16 December 2022, the Food and Drug Administration (FDA) conducted a Licensing Seminar held at the Bohol Tropics, Tagbilaran City, Bohol, pursuant to DOH Administrative Order No. 2020-0017, entitled “Revised Guidelines on the Unified Licensing Requirements and Procedures of the FDA, Repealing Administrative Order No. 2016-0003”.

The Licensing Seminar was organized and facilitated by the FDA-Policy and Planning Service (PPS) in collaboration with the Bohol Pharmacist Association and Drugstore Association of the Philippines (DSAP/CPhAD) Bohol Chapter, and was participated by the latter’s members.

The activity provided an understanding of the mandate, functions, and services offered by the FDA to promote the current regulations and process in the application of drug outlets’ License to Operate (LTO), and the importance of Good Dispensing, Distribution, and Storage Practices Management to guarantee and provide access to safe and quality health products to the general public. The use of eServices Portal System in the LTO application initial, renewal or variation, Certificate of Product Registration for certain drug products, and Compassionate Special Permit providing convenient transaction by qualified or authorized personnel of the establishments, was also discussed.

The conducted activity is part of the agency’s advocacy and commitment to deliver seminars in every part of the Philippines, which will ultimately result in the compliance of its regulated entities. Thus, ensuring safe, quality, and efficacious health products in the market.

See more:>>